Metastatic Castration-Resistant Prostate Cancer: Optimizing Patient-Centric Management – Ordre des pharmaciens du Québec (OPQ)

By the end of this course, the participant will be able to:

Discuss the role of specialists, family physicians and pharmacists and the importance of communication between healthcare professionals in the optimal, patient-centric management of prostate cancer
Describe the role of Androgen Receptor Axis-Targeted (ARAT) agents in treating metastatic castration resistant prostate cancer (mCRPC) and know which ARAT agents are available in Canada
Identify and manage the dose-adjustments, drug-drug interactions and adverse effects of ARAT agents abiraterone acetate and enzalutamide
Describe the most appropriate treatment options for different patient profiles and effectively counsel patients regarding their treatment options, adverse effects and the importance of adherence